eNamptcumab | Interleukin Related interleukin-related.com

Product Name :
eNamptcumab

Search keywords :
ALT-100

drugId :
null

Target Vo:
Nicotinamide phosphoribosyltransferase

Target Vo Short Name :
NAMPT

Moa_Name:
Nicotinamide phosphoribosyltransferase inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Aqualung Therapeutics Corp

Active Company_Name :
Aqualung Therapeutics Corp

Active Indication_Name:
Respiratory Distress Syndrome, Adult

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Phase 2 Clinical

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Opicinumab custom synthesis
Nipocalimab supplier
Phospho-STAT1 (Tyr701) Antibody: Phospho-STAT1 (Tyr701) Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 87 kDa, targeting to Phospho-STAT1 (Tyr701). It can be used for ICC/IF,WB,IHC-F,IHC-P,IP,ELISA assays with tag free, in the background of Human, Mouse, Rat, Monkey.

Author: Interleukin Related

Related Posts